Pancreatic ductal adenocarcinoma has a five-year survival rate of roughly 13 percent, according to the American Cancer ...

A ONE-minute cancer drug injection will speed up treatment for thousands of NHS patients. Pembrolizumab, given to about 14,000 patients a year, will be available as a quicker jab instead of a ...

Pancreatic cancer has long been oncology’s most stubborn adversary. Fewer than 13% of patients survive five years after ...

In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer recurrence and death by nearly 50 percent over five years when compared with ...

May 21 () - Moderna and Merck's combination therapy for skin cancer helped reduce risk of cancer spreading to another ‌part ...

Engineers from the University of Houston, MIT and Harvard have developed a new mRNA-based strategy that dramatically amplifies the T-cell response to vaccines - an advance that could lead to far more ...

Development of a DNA-based lung cancer vaccine in the United Kingdom received funding for 2 years of laboratory research and initial manufacture of 3000 doses, according to a press release from the ...

Roche brings subcutaneous Atezolizumab to India, shot costs Rs 3.7 lakh per dose with most patients needing around six doses ...

UH engineers helped develop an mRNA-based strategy that boosts cancer-fighting T cells and, in mouse studies, helped ...

U.S. Personalized Cancer Vaccine Market was valued at USD 76.8 million in 2025 and is expected to reach USD 2.743 billion by 2035 owing to the presence of most prominent personalized vaccine ...

Stony Brook Cancer Center is one of 160 sites worldwide participating in the FLAMINGO-01 Phase III clinical trial.

Discover why more men are getting the HPV vaccine in Singapore and understand the growing awareness of its significant health benefits for both genders. Read more at straitstimes.com. Read more at ...